Skip to main content

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1180 Accesses

Nasopharyngeal carcinoma (NPC) is unique for the distinct racial and geographic distribution (Fig. 5.1). Parkin et al. (2002) reported that the age-standardized incidence rate (ASR/100,000/year) in 1993-1997 ranged from <1 among Caucasians to >20 among Southern Chinese male populations. There is marked variation in incidence among Chinese residing in different parts of China, with ASR ranging from 1.7 in Tianjin (in the north) to 21.4 in Hong Kong (in the south). There is also marked variation in incidence among different ethnic groups in Singapore, with ASR ranging from 1.3 among Indians to 16.3 among Chinese

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Al-Amro A, Al-Rajhi N, Khafaga Y et al. (2005) Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 62:508–513

    PubMed  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG et al. (1998a) Chemora-diotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16(4):1310–1317

    CAS  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PGS et al. (1998b) Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: progress report. J Clin Oncol 17:385a [abstract]

    Google Scholar 

  • Armstrong RW, Imrey PB, Lye MS et al. (1998) Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 77(2):228–235

    Article  PubMed  CAS  Google Scholar 

  • Baujat B, Audry H, Bourhis J et al. (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64(1):47–56

    PubMed  CAS  Google Scholar 

  • Buell P (1973) Race and place in the etiology of nasopharyn-geal cancer: a study based on California death certificates. Int J Cancer 11:268–272

    Article  PubMed  CAS  Google Scholar 

  • Burt RD, Vaughan TL, McKnight B et al. (1996) Associations between human leukocyte antigen type and nasopharyn-geal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 5(11):879–887

    PubMed  CAS  Google Scholar 

  • Butler EB, Teh BS, Grant WH et al. (1999) SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45(1):21–32

    PubMed  CAS  Google Scholar 

  • Chan J, Bray F, McCarron P et al. (2005a) Nasopharyngeal carcinoma. Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours. IARC, Lyon, pp 85–97

    Google Scholar 

  • Chan AT, Leung SF, Ngan RK et al. (2005b) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopha-ryngeal carcinoma. J Natl Cancer Inst 97(7):536–539

    Article  CAS  Google Scholar 

  • Chan AT, Ma BY, Lo YM et al. (2004) Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr Virus DNA. J Clin Oncol 22:3053–3060

    Article  PubMed  CAS  Google Scholar 

  • Chan AT, Te o PM, Leung TW et al. (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33(3):569–577

    PubMed  CAS  Google Scholar 

  • Chan AT, Teo PM, Ngan RK et al. (2002) Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locore-gionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20(8):2038–2044

    Article  PubMed  CAS  Google Scholar 

  • Cheng JC, Chao KS, Low D (2001) Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96(2):126–132

    Article  PubMed  CAS  Google Scholar 

  • Chen HH, Tsai ST, Wang MS et al. (2006) Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66(5):1408–1414

    PubMed  Google Scholar 

  • Chen HJ, Leung SW, Su CY (2001) Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinomas. Am J Clin Oncol 24(3):255–258

    Article  PubMed  CAS  Google Scholar 

  • Chi KH, Chang YC, Guo WY et al. (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52(5):1238–1244

    Article  PubMed  CAS  Google Scholar 

  • Chua DT, Sham JS, Choy D et al. (1998) Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopha-ryngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer 83(11):2270–2283

    CAS  Google Scholar 

  • Cvitkovic E, Eschwege F, Rahal M et al. (1996) Preliminary results of trial comparing neoadjuvant chemotherapy (cis-platin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression free survival. I Int J Radiat Oncol Biol Phys 35:463–469

    CAS  Google Scholar 

  • Dickson RI, Flores AD (1985) Nasopharyngeal carcinoma: an evaluation of 134 patients treated between 1971–1980. Laryngoscope 95(3):276–283

    Article  PubMed  CAS  Google Scholar 

  • Fang FM, Chien CY, Tsai WL et al. (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 72:356–364

    PubMed  Google Scholar 

  • Fang FM, Chiu HC, Kuo WR et al. (2002) Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys 53(4):959–968

    PubMed  Google Scholar 

  • Fang FM, Tsai WL, Chen HC et al. (2007) Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques. Cancer 109(2):313–321

    Article  PubMed  Google Scholar 

  • Ferlay J, Bray F, Pisani P et al. (2004) GLOBOCAN 2002. Cancer incidence, mortality, and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. IARC, Lyon

    Google Scholar 

  • Feng BJ, Huang W, Shugart YY et al. (2002) Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31:395–399

    PubMed  CAS  Google Scholar 

  • Friborg J, Wohlfahrt J, Koch A et al. (2005) Cancer susceptibility in nasopharyngeal carcinoma families—a population-based cohort study. Cancer Res 65:8567–8572

    Article  PubMed  CAS  Google Scholar 

  • Geara FB, Sanguineti G, Tucker SL et al. (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 43(1):53–61

    Article  PubMed  CAS  Google Scholar 

  • Hara W, Loo BW, Goffinet DR et al. (2008) Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 71(2):393–400

    PubMed  Google Scholar 

  • Hareyama M, Sakata K, Shirato H et al. (2002) A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 94(8):2217–2223

    Article  PubMed  CAS  Google Scholar 

  • Heng DM, Wee J, Fong KW et al. (1999) Prognostic factors in 677 patients in Singapore with nondisseminated nasopha-ryngeal carcinoma. Cancer 86(10):1912–1920

    Article  PubMed  CAS  Google Scholar 

  • Ho JH (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 4(4):182–198

    PubMed  CAS  Google Scholar 

  • Hui EP, Ma BB, Leung SF et al. (2007) Efficacy of neoadjuvant docetaxel and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): a randomized phase II study. J Clin Oncol 25(18S):6037

    Google Scholar 

  • Jia WH et al. (2004) Familial risk and clustering of nasopha-ryngeal carcinoma in Guangdong, China. Cancer 101 (2):363–369

    Article  PubMed  Google Scholar 

  • Jian JJ, Cheng SH, Tsai SY et al. (2002) Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyper-fractionated radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 53:344–352

    PubMed  Google Scholar 

  • Johnson FM, Garden AS, Palmer JL et al. (2005) A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopha-ryngeal carcinoma. Int J Radiat Oncol Biol Phys 63:717–724

    PubMed  CAS  Google Scholar 

  • Kam MK, Chau RM, Suen J et al. (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56(1):145–157

    PubMed  Google Scholar 

  • Kam MK, Leung SF, Zee B et al. (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873–4879

    Article  PubMed  Google Scholar 

  • Kam MK, Teo PM, Chau RM, et al. (2004) Treatment of nasopha-ryngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440–1450

    PubMed  Google Scholar 

  • Ko JY, Sheen TS, Hsu MM et al. (1998) Familial clustering of nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 118:736–737

    PubMed  CAS  Google Scholar 

  • Kwong DL, Pow EH, Sham JS et al. (2004a) Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101(7):1584–1593

    Article  Google Scholar 

  • Kwong DL, Sham JS, Au GK et al. (2004b) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22(13):2643–2653

    Article  CAS  Google Scholar 

  • Kwong DL, Sham JS, Chua DT et al. (1997) The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 39(3):703–710

    PubMed  CAS  Google Scholar 

  • Kwong DL, Sham JS, Leung LH et al. (2006) Preliminary results of radiation dose escalation for locally advanced naso pharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64(2):374–381

    PubMed  Google Scholar 

  • Lee AW, Au JS, Teo PM et al. (2004) Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/ AJCC staging system. Clin Oncol 16(4):269–276

    Article  CAS  Google Scholar 

  • Lee AW, Chan DK, Fowler JF et al. (1995) Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 36(1):24–31

    Article  PubMed  CAS  Google Scholar 

  • Lee AW, Foo W, Chappell R et al. (1998) Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40(1):35–42

    Article  PubMed  CAS  Google Scholar 

  • Lee AW, Foo W, Mang O et al. (2003) Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980–99): an encouraging reduction in both incidence and mortality. Int J Cancer 103(5):680–685

    Article  PubMed  CAS  Google Scholar 

  • Lee AW, Kwong DL, Leung SF et al. (2002a) Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53(1):75–85

    Google Scholar 

  • Lee AW, Lau WH, Tung SY et al. (2005a) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966–6975

    Article  CAS  Google Scholar 

  • Lee AWM, Ng WT, Hung WM et al. (2009) Major Late Toxicities Following Conformal Radiotherapy for Nasopharyngeal Carcinoma — Patient and Treatment Related Risk Factors. Int J Radiat Oncol Biol Phys 73(4):1121–1128

    PubMed  Google Scholar 

  • Lee AW, Poon YF, Foo W et al. (1992) Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23(2):261–270

    PubMed  CAS  Google Scholar 

  • Lee AW, Sze WM, Au SK et al. (2005b) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61:1107–1116

    Google Scholar 

  • Lee AW, Tung SY, Chan AT et al. (2006) Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66:142–151

    PubMed  Google Scholar 

  • Lee AW, Yau TK, Wong HM et al. (2005c) Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fraction-ation. Int J Radiat Oncol Biol Phys 63:1331–1338

    Article  Google Scholar 

  • Lee N, Xia P, Quivey JM et al. (2002b) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53(1):12–22

    Google Scholar 

  • Leung SF, Chan AT, Zee B et al. (2003) Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer 98(2):288–291

    Article  PubMed  Google Scholar 

  • Leung TW, Tung SY, Sze WK et al. (2005) Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck 27(7):555–565

    Article  PubMed  Google Scholar 

  • Leung SF, Zee B, Ma B et al. (2006) Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor node-metastasis staging prognostication in nasopharyn-geal carcinoma. J Clin Oncol 24:5414–5418

    Article  PubMed  CAS  Google Scholar 

  • Lin JC, Chen KY, Jan JS et al. (1996) Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36:1127–1136

    PubMed  CAS  Google Scholar 

  • Lin JC, Jan JS, Hsu CY et al. (2003) Concurrent chemoradiother-apy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21:631–637

    Article  PubMed  Google Scholar 

  • Lin JC, Liang WM, Jan JS et al. (2004) Another way to estimate outcome of advanced nasopharyngeal carcinoma—is concurrent chemoradiotherapy adequate. Int J Radiat Oncol Biol Phys 60:156–164

    Article  PubMed  Google Scholar 

  • Lo AK, Huang P, Lo KW et al. (2004a) Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 109(6):919–925

    Article  CAS  Google Scholar 

  • Lo KW, To KF, Huang DP (2004b) Focus on nasopharyngeal carcinoma. Cancer Cell 5(5):423–428

    Article  CAS  Google Scholar 

  • Loh KS, Goh BC, Lu J et al. (2006) Familial nasopharyngeal carcinoma in a cohort of 200 patients. Arch Otolaryngol Head Neck Surg 132(1):82–85

    Article  PubMed  Google Scholar 

  • Lovell SJ, Wong HB, Loh KS et al. (2005) Impact of dysphagia on quality-of-life in nasopharyngeal carcinoma. Head Neck 27(10):864–872

    Article  PubMed  Google Scholar 

  • Ma J, Mai HQ, Hong MH et al. (2001) Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations? Int J Radiat Oncol Biol Phys 50(5):1181–1189

    PubMed  CAS  Google Scholar 

  • McMillan AS, Pow EH, Leung WK et al. (2004) Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil 31(6):600–608

    Article  PubMed  CAS  Google Scholar 

  • Oh JL, Vokes EE, Kies MS et al. (2003) Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol 14:564–569

    Article  PubMed  CAS  Google Scholar 

  • Ozyar E, Yildiz F, Akyol FH et al. (1999) Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer. Int J Radiat Oncol Biol Phys 44(5):1079–1087

    PubMed  CAS  Google Scholar 

  • Palazzi M, Guzzo M, Tomatis S et al. (2004) Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 60(5):1451–1458

    PubMed  Google Scholar 

  • Parkin DM, Whelan SL, Ferlay J et al. (2002) Cancer incidence in five continents, vol VIII. IARC, Lyon

    Google Scholar 

  • Pathmanathan R, Prasad U, Sadler R et al. (1995) Clonal proliferations of cells infected with Epstein-Barr virus in prein-vasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698

    Article  PubMed  CAS  Google Scholar 

  • Perez CA, Devineni VR, Marcial-Vega V et al. (1992) Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 23(2):271–280

    PubMed  CAS  Google Scholar 

  • Poirier S, Ohshima H, de-The G et al. (1987) Volatile nitro-samine levels in common foods from Tunisia, south China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 39(3):293–296

    Article  PubMed  CAS  Google Scholar 

  • Pow HN, Kwong LW, McMillan S et al. (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66(4):981–991

    PubMed  Google Scholar 

  • Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cance Biol 12(6):431–441

    Article  CAS  Google Scholar 

  • Rischin D, Corry J, Smith J et al. (2002) Excellent disease control and survival in patients with advanced nasopharyn-geal cancer treated with chemoradiation. J Clin Oncol 20:1845–1852

    Article  PubMed  CAS  Google Scholar 

  • Sun LM, Epplein M, Li CI et al. (2005) Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002. Am J Epidemiol 162(12):1174–1178

    Article  PubMed  Google Scholar 

  • Wee J, Tan EH, Tai BC et al. (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730–6738

    Article  PubMed  CAS  Google Scholar 

  • Wolden SL, Chen WC, Pfister DG et al. (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64(1):57–62

    PubMed  Google Scholar 

  • Wolden SL, Zelefsky MJ, Kraus DH et al. (2001) Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19:1105–1110

    PubMed  CAS  Google Scholar 

  • Wu Y, Hu WH, Xia YF et al. (2007) Quality of life of nasopha-ryngeal carcinoma survivors in Mainland China. Qual Life Res 16(1):65–74

    Article  PubMed  CAS  Google Scholar 

  • Xia P, Fu KK, Wong GW et al. (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48(2):329–337

    PubMed  CAS  Google Scholar 

  • Xiong W, Zeng ZY, Xia JH et al. (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64(6):1972–1974

    Article  PubMed  CAS  Google Scholar 

  • Yau TK, Lee AW, Wong HM et al. (2006) Induction chemotherapy with Cisplatin and Gemcitabine followed by accelerated radiotherapy and concurrent Cisplatin in patients with stage IV(A-B) Nasopharyngeal Carcinoma. Head Neck 28:880–887

    Article  PubMed  Google Scholar 

  • Yeung RM, Wong D, Au KH et al. (2005) To compare the quality of life of patients with advanced nasopharyngeal carcinoma treated with radical radiotherapy alone versus concurrent chemoradiotherapy. East-West Sympo sium on Nasopharyn-geal Cancer, Toronto, (15):19–20 [abstract]

    Google Scholar 

  • Yi JL, Gao L, Huang XD et al. (2006) Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a singly institution. Int J Radiat Oncol Biol Phys 65(1):161–168

    PubMed  Google Scholar 

  • Yu MC, Ho JH, Lai SH et al. (1986) Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case— control study in Hong Kong. Cancer Res 46(2):956–961

    PubMed  CAS  Google Scholar 

  • Yuan J, Wang XL, Xiang YB et al. (2000) Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 85(3):358–363

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Zhao C, Peng PJ et al. (2005) Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopha- ryngeal carcinoma: preliminary results. J Clin Oncol 23:8461–8468

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lee, A.W.M., Yeung, R.M.W., Ng, W.T. (2009). Nasopharynx. In: Harari, P.M., Connor, N.P., Grau, C. (eds) Functional Preservation and Quality of Life in Head and Neck Radiotherapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73232-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-73232-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-73231-0

  • Online ISBN: 978-3-540-73232-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics